Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.

[1]  X. Causse,et al.  Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide study , 2018, Cancer.

[2]  S. Friedman,et al.  Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. , 2017, Journal of hepatology.

[3]  Mahboob Rahman,et al.  Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[4]  Yanning Liu.  Sensitivity analyses for informative censoring in survival data: A trial example , 2017, Journal of biopharmaceutical statistics.

[5]  J. West,et al.  Risk of hepatocellular carcinoma among individuals with different aetiologies of cirrhosis: a population‐based cohort study , 2017, Alimentary pharmacology & therapeutics.

[6]  O. Weiland,et al.  Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication. , 2017, Journal of hepatology.

[7]  T. Lash,et al.  The clinical course of alcoholic cirrhosis: development of comorbid diseases. A Danish nationwide cohort study , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[8]  V. de Lédinghen,et al.  Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort) , 2015, Hepatology.

[9]  Gary S Collins,et al.  Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement , 2015, BMC Medicine.

[10]  D. Kansagara,et al.  Screening for Hepatocellular Carcinoma in Chronic Liver Disease , 2014, Annals of Internal Medicine.

[11]  Amit G. Singal,et al.  Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis , 2014, PLoS medicine.

[12]  J. Ferlay,et al.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. , 2013, European journal of cancer.

[13]  H. Sørensen,et al.  Risk for Hepatocellular Carcinoma in Patients With Alcoholic Cirrhosis , 2012, Annals of Internal Medicine.

[14]  V. Vilgrain,et al.  Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3‐ and 6‐month periodicities , 2011, Hepatology.

[15]  J. Bruix,et al.  Management of hepatocellular carcinoma: An update , 2011, Hepatology.

[16]  I. White,et al.  Multiple imputation using chained equations: Issues and guidance for practice , 2011, Statistics in medicine.

[17]  X. Causse,et al.  585 A FRENCH MULTICENTRIC LONGITUDINAL DESCRIPTIVE STUDY OF HEPATOCELLULAR CARCINOMA MANAGEMENT (THE CHANGH COHORT): PRELIMINARY RESULTS , 2010 .

[18]  M. Lucey.  Management of alcoholic liver disease. , 2009, Clinics in liver disease.

[19]  Charles E McCulloch,et al.  Relaxing the rule of ten events per variable in logistic and Cox regression. , 2007, American journal of epidemiology.

[20]  J. Bruix,et al.  Management of hepatocellular carcinoma , 2005, Hepatology.

[21]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[22]  M. Ziol,et al.  Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications. , 2017, Gastroenterology.

[23]  N. Chavez-Tapia,et al.  Clinical practice guidelines: Management of Hepatocellular Carcinoma , 2014 .

[24]  L. Rodrigo,et al.  Annual incidence of hepatocellular carcinoma among patients with alcoholic cirrhosis and identification of risk groups. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[25]  T. Roskams,et al.  EASL clinical practical guidelines: management of alcoholic liver disease. , 2012, Journal of hepatology.

[26]  Riccardo Lencioni,et al.  EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. , 2012, Journal of hepatology.

[27]  V. Mazzaferro,et al.  EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. , 2012, European journal of cancer.